Are target-family-privileged substructures truly privileged?

被引:82
作者
Schnur, DM [1 ]
Hermsmeier, MA [1 ]
Tebben, AJ [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
关键词
D O I
10.1021/jm0502900
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One of the early and effective approaches to G-coupled protein receptor target family library design was the analysis of a set of ligands for frequently occurring chemical moieties or substructures. Various methods ranging from frameworks analysis to pharmacophores have been employed to find these so-called target-family-privileged substructures. Although the use of these substructures is common practice in combinatorial library design and has produced leads,(1) the methods used for finding them rarely verified their selectivity for the particular target family from which they were derived. The frequency of occurrence among ligands associated with a target receptor family is not a sufficient criterion for those substructures to receive the label of target-family-privileged substructure. This study explores the question of selectivity of ClassPharmer(2) generated fragments for a series of target families: GPCRs, nuclear hormone receptors, serine proteases, protein kinases, and ligand-gated ion channels. In addition, a GPCR focused library and a random set of 10k compounds are examined in terms of their target-family-privileged-substructure composition. The results challenge the combinatorial chemistry concept of target-family-privileged substructures and suggest that many of these fragments may simply be drug-like or attractive for various receptors in accordance with the original definition of privileged substructures.(3,4)
引用
收藏
页码:2000 / 2009
页数:10
相关论文
共 26 条
[11]  
KUBINYI H, 2004, COMPUT MED CHEM DRUG, P539
[12]   Design of a gene family screening library targeting G-protein coupled receptors [J].
Lamb, ML ;
Bradley, EK ;
Beaton, G ;
Bondy, SS ;
Castellino, AJ ;
Gibbons, PA ;
Suto, MJ ;
Grootenhuis, PDJ .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2004, 23 (01) :15-21
[13]   The different strategies for designing GPCR and kinase targeted libraries [J].
Lowrie, JF ;
Delisle, RK ;
Hobbs, DW ;
Diller, DJ .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2004, 7 (05) :495-510
[14]   New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures [J].
Mason, JS ;
Morize, I ;
Menard, PR ;
Cheney, DL ;
Hulme, C ;
Labaudiniere, RF .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) :3251-3264
[15]   Chemical substructures in drug discovery [J].
Merlot, C ;
Domine, D ;
Cleva, C ;
Church, DJ .
DRUG DISCOVERY TODAY, 2003, 8 (13) :594-602
[16]   (R)-3-amidinophenylalanine-derived inhibitors of factor Xa with a novel active-site binding mode [J].
Mueller, MM ;
Sperl, S ;
Stürzebecher, J ;
Bode, W ;
Moroder, L .
BIOLOGICAL CHEMISTRY, 2002, 383 (7-8) :1185-1191
[17]   Medicinal chemistry of target family-directed masterkeys [J].
Müller, G .
DRUG DISCOVERY TODAY, 2003, 8 (15) :681-691
[18]   Performance of 3D-database molecular docking studies into homology models [J].
Oshiro, C ;
Bradley, EK ;
Eksterowicz, J ;
Evensen, E ;
Lamb, ML ;
Lanctot, JK ;
Putta, S ;
Stanton, R ;
Grootenhuis, PDJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) :764-767
[19]   Crystal structure of rhodopsin: A G protein-coupled receptor [J].
Palczewski, K ;
Kumasaka, T ;
Hori, T ;
Behnke, CA ;
Motoshima, H ;
Fox, BA ;
Le Trong, I ;
Teller, DC ;
Okada, T ;
Stenkamp, RE ;
Yamamoto, M ;
Miyano, M .
SCIENCE, 2000, 289 (5480) :739-745
[20]   Privileged structures - An update [J].
Patchett, AA ;
Nargund, RP .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35, 2000, 35 :289-298